(NIC) Nicolet Bankshares - NYSE
Sector: Financial Services | Industry: Banks - Regional | Exchange: NYSE (USA) | Market Cap: 3.103m USD | Total Return: 26.6% in 12m
Avg Turnover: 32.9M
EPS Trend: 97.7%
Qual. Beats: 8
Rev. Trend: 87.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Nicolet Bankshares, Inc. (NIC) is a bank holding company headquartered in Green Bay, Wisconsin, operating primarily through Nicolet National Bank. It provides a comprehensive suite of financial services, including commercial and retail banking, wealth management, and fiduciary services across Wisconsin, Michigan, and Minnesota. The company’s lending portfolio is diversified across commercial and industrial loans, agricultural financing, and residential real estate mortgages.
As a regional bank, Nicolet relies on a spread-based business model, generating revenue primarily through the Net Interest Margin (NIM) between deposit costs and loan yields. Regional banks in the Upper Midwest often maintain significant exposure to the agricultural sector, where credit performance is tied to commodity price cycles and federal insurance programs. For deeper insights into these financial metrics, consider reviewing the latest valuation data on ValueRay.
The institution also offers ancillary services such as international banking, cash management, and mortgage refinancing to support its core deposit and lending operations. Since its incorporation in 2000, the firm has expanded its footprint through organic growth and strategic positioning within its three-state service area.
- Upper Midwest community bank consolidation drives asset and deposit growth
- Net interest margin sensitivity to Federal Reserve monetary policy shifts
- Agricultural and commercial real estate loan performance impacts credit quality
- Wealth management fee income expansion diversifies non-interest revenue streams
- Regional economic stability in Wisconsin and Michigan influences loan demand
| Net Income: 133.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.75 > 1.0 |
| NWC/Revenue: -2.38k% < 20% (prev -1.24k%; Δ -1.14k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 128.0m > Net Income 133.3m |
| Net Debt (-1.93b) to EBITDA (177.1m): -10.90 < 3 |
| Current Ratio: 0.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.2m) vs 12m ago -2.68% < -2% |
| Gross Margin: 65.56% > 18% (prev 66.75%; Δ -1.19% > 0.5%) |
| Asset Turnover: 4.27% > 50% (prev 5.87%; Δ -1.60% > 0%) |
| Interest Coverage Ratio: 0.78 > 6 (EBIT TTM 165.8m / Interest Expense TTM 213.1m) |
| A: -0.80 (Total Current Assets 177.8m - Total Current Liabilities 12.6b) / Total Assets 15.6b |
| B: 0.05 (Retained Earnings 706.1m / Total Assets 15.6b) |
| C: 0.01 (EBIT TTM 165.8m / Avg Total Assets 12.3b) |
| D: 0.17 (Book Value of Equity 2.26b / Total Liabilities 13.3b) |
| Altman-Z'' = -4.83 = D |
| DSRI: 2.04 (Receivables 54.4m/26.8m, Revenue 523.8m/526.9m) |
| GMI: 1.02 (GM 66.75% / 65.56%) |
| AQI: 1.12 (AQ_t 0.98 / AQ_t-1 0.87) |
| SGI: 0.99 (Revenue 523.8m / 526.9m) |
| TATA: 0.00 (NI 133.3m - CFO 128.0m) / TA 15.6b) |
| Beneish M = -2.08 (Cap -4..+1) = BB |
As of June 20, 2026, the stock is trading at USD 146.85 with a total of 626,870 shares traded.
Over the past week, the price has changed by -0.25%,
over one month by +4.54%,
over three months by +4.89% and
over the past year by +26.63%.
Nicolet Bankshares has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold NIC.
- StrongBuy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 174.2 | 18.6% |
P/E Trailing = 17.158
P/E Forward = 14.8368
P/S = 7.239
P/B = 1.3612
P/EG = 1.921
Revenue TTM = 523.8m USD
EBIT TTM = 165.8m USD
EBITDA TTM = 177.1m USD
Long Term Debt = 180.0m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 180.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.93b USD (calculated: Debt 180.0m - CCE 2.11b)
Enterprise Value = 1.17b USD (3.10b + Debt 180.0m - CCE 2.11b)
Interest Coverage Ratio = 0.78 (Ebit TTM 165.8m / Interest Expense TTM 213.1m)
EV/FCF = 9.52x (Enterprise Value 1.17b / FCF TTM 123.2m)
FCF Yield = 10.51% (FCF TTM 123.2m / Enterprise Value 1.17b)
FCF Margin = 23.52% (FCF TTM 123.2m / Revenue TTM 523.8m)
Net Margin = 25.45% (Net Income TTM 133.3m / Revenue TTM 523.8m)
Gross Margin = 65.56% ((Revenue TTM 523.8m - Cost of Revenue TTM 180.4m) / Revenue TTM)
Gross Margin QoQ = 46.44% (prev 71.24%)
Tobins Q-Ratio = 0.08 (Enterprise Value 1.17b / Total Assets 15.6b)
Interest Expense / Debt = 118.4% (Interest Expense 213.1m / Debt 180.0m)
Taxrate = 19.62% (32.5m / 165.8m)
NOPAT = 133.3m (EBIT 165.8m * (1 - 19.62%))
Current Ratio = 0.01 (Total Current Assets 177.8m / Total Current Liabilities 12.6b)
Debt / Equity = 0.08 (Debt 180.0m / totalStockholderEquity, last quarter 2.26b)
Debt / EBITDA = -10.90 (Net Debt -1.93b / EBITDA 177.1m)
Debt / FCF = -15.67 (Net Debt -1.93b / FCF TTM 123.2m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.09% (Net Income 133.3m / Total Assets 15.6b)
RoE = 9.01% (Net Income TTM 133.3m / Total Stockholder Equity 1.48b)
RoCE = 9.99% (EBIT 165.8m / Capital Employed (Equity 1.48b + L.T.Debt 180.0m))
RoIC = 4.56% (NOPAT 133.3m / Invested Capital 2.92b)
WACC = 7.31% (E(3.10b)/V(3.28b) * Re(7.73%) + (debt cost/tax rate unavailable))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 0.0 | Cagr: 0.25%
[DCF] Terminal Value 73.79% ; FCFF base≈129.3m ; Y1≈117.8m ; Y5≈102.7m
[DCF] Fair Price = 167.6 (EV 1.63b - Net Debt -1.93b = Equity 3.56b / Shares 21.3m; r=8.35% [WACC [floored]]; 5y FCF grow -11.05% → 2.50% )
EPS Correlation: 97.68 | EPS CAGR: 20.90% | SUE: 1.06 | # QB: 8
Revenue Correlation: 87.20 | Revenue CAGR: 14.94% | SUE: -0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.89 | Chg30d=-6.39% | Revisions=-50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=3.09 | Chg30d=-6.44% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=11.90 | Chg30d=-4.90% | Revisions=-50% | GrowthEPS=+21.2% | GrowthRev=+73.1%
EPS next Year (2027-12-31): EPS=13.29 | Chg30d=-7.35% | Revisions=-50% | GrowthEPS=+11.7% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: -50%